Katja Wosikowski

1.2k total citations
30 papers, 954 citations indexed

About

Katja Wosikowski is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Katja Wosikowski has authored 30 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Oncology and 5 papers in Genetics. Recurrent topics in Katja Wosikowski's work include Cancer Treatment and Pharmacology (5 papers), Estrogen and related hormone effects (5 papers) and Cancer therapeutics and mechanisms (5 papers). Katja Wosikowski is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Estrogen and related hormone effects (5 papers) and Cancer therapeutics and mechanisms (5 papers). Katja Wosikowski collaborates with scholars based in United States, Germany and Switzerland. Katja Wosikowski's co-authors include Susan E. Bates, Urs Eppenberger, R. Löser, Willy Küng, Benno Rattel, Danita H. Schuurhuis, Max Hasmann, Bruce Dickstein, Miguel Saceda and Kenneth D. Paull and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Katja Wosikowski

29 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katja Wosikowski United States 17 459 415 142 124 113 30 954
Steven Sugarman United States 14 453 1.0× 544 1.3× 152 1.1× 198 1.6× 83 0.7× 20 1.2k
Mélanie Di Benedetto France 18 698 1.5× 356 0.9× 235 1.7× 56 0.5× 122 1.1× 33 1.3k
Denise K. Oelschlager United States 20 602 1.3× 325 0.8× 197 1.4× 155 1.3× 258 2.3× 41 1.2k
M V Blagosklonny United States 9 574 1.3× 426 1.0× 130 0.9× 117 0.9× 110 1.0× 11 989
Robert D. Bruno United States 20 450 1.0× 508 1.2× 167 1.2× 207 1.7× 211 1.9× 34 1.4k
José M. Arencibia United States 21 582 1.3× 262 0.6× 67 0.5× 146 1.2× 125 1.1× 33 1.1k
Emily Powell United States 19 523 1.1× 338 0.8× 249 1.8× 157 1.3× 148 1.3× 42 1.1k
Willy Kueng Switzerland 9 599 1.3× 459 1.1× 344 2.4× 200 1.6× 66 0.6× 11 1.2k
A. M. Burger United States 15 799 1.7× 368 0.9× 158 1.1× 73 0.6× 92 0.8× 30 1.2k
Shikha Gaur United States 16 487 1.1× 218 0.5× 206 1.5× 62 0.5× 87 0.8× 28 875

Countries citing papers authored by Katja Wosikowski

Since Specialization
Citations

This map shows the geographic impact of Katja Wosikowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Wosikowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Wosikowski more than expected).

Fields of papers citing papers by Katja Wosikowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Wosikowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Wosikowski. The network helps show where Katja Wosikowski may publish in the future.

Co-authorship network of co-authors of Katja Wosikowski

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Wosikowski. A scholar is included among the top collaborators of Katja Wosikowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Wosikowski. Katja Wosikowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wosikowski, Katja, et al.. (2024). Ritonavir reverses resistance to docetaxel and cabazitaxel in prostate cancer cells with acquired resistance to docetaxel. Cancer Drug Resistance. 7. 3–3. 2 indexed citations
2.
Huber‐Ruano, Isabel, C. Raventós, Isabel Cuartas, et al.. (2017). An antisense oligonucleotide targeting TGF-β2 inhibits lung metastasis and induces CD86 expression in tumor-associated macrophages. Annals of Oncology. 28(9). 2278–2285. 24 indexed citations
3.
4.
5.
Seibel, Jan, Carlo Pergola, Oliver Werz, et al.. (2015). Bronchipret® syrup containing thyme and ivy extracts suppresses bronchoalveolar inflammation and goblet cell hyperplasia in experimental bronchoalveolitis. Phytomedicine. 22(13). 1172–1177. 20 indexed citations
6.
Seibel, Jan, Carlo Pergola, Oliver Werz, Katja Wosikowski, & Jutta Haunschild. (2013). A combination of thyme and primula dry extracts possesses antitussive activity and inhibits leukotriene formation. European Respiratory Journal. 42(Suppl 57). P743–P743. 1 indexed citations
7.
Peters, Godefridus J., et al.. (2006). 614 POSTER Synergistic interaction between erlotinib and JM-118, the active metabolite of satraplatin. European Journal of Cancer Supplements. 4(12). 185–185. 1 indexed citations
8.
Nathan, Faith E., C. Sternberg, Oliver Sartor, et al.. (2005). Satraplatin: A new treatment option for patients with hormone refractory prostate cancer. Journal of Clinical Oncology. 23(16_suppl). 4802–4802. 4 indexed citations
9.
Lang, Stephan, et al.. (2004). Inhibition of the invasion capacity of carcinoma cells by WX‐UK1, a novel synthetic inhibitor of the urokinase‐type plasminogen activator system. International Journal of Cancer. 110(6). 815–824. 50 indexed citations
10.
Besch, Robert, Michael J. Flaig, Christian A. Sander, et al.. (2003). Protease Inhibitors Prevent Plasminogen-Mediated, But Not Pemphigus Vulgaris-Induced, Acantholysis in Human Epidermis. Biological Chemistry. 384(2). 311–5. 10 indexed citations
11.
Wosikowski, Katja, et al.. (2002). WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells.. PubMed. 62(4). 1057–62. 79 indexed citations
12.
Wosikowski, Katja, Jeffrey A. Silverman, Philippe C. Bishop, John Mendelsohn, & Susan E. Bates. (2000). Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1497(2). 215–226. 22 indexed citations
13.
Wosikowski, Katja, Danita H. Schuurhuis, K. Johnson, et al.. (1997). Identification of Epidermal Growth Factor Receptor and c-erbB2 Pathway Inhibitors by Correlation With Gene Expression Patterns. JNCI Journal of the National Cancer Institute. 89(20). 1505–1515. 103 indexed citations
14.
Wosikowski, Katja, Danita H. Schuurhuis, Geert J.P.L. Kops, Miguel Saceda, & Susan E. Bates. (1997). Altered gene expression in drug-resistant human breast cancer cells.. PubMed. 3(12 Pt 1). 2405–14. 74 indexed citations
15.
Dickstein, Bruce, Katja Wosikowski, & Susan E. Bates. (1995). Increased resistance to cytotoxic agents in ZR75B human breast cancer cells transfected with epidermal growth factor receptor. Molecular and Cellular Endocrinology. 110(1-2). 205–211. 47 indexed citations
16.
Mueller, Heinz, et al.. (1994). Differential signal transduction of epidermal‐growth‐factor receptors in hormone‐dependent and hormone‐independent human breast cancer cells. European Journal of Biochemistry. 221(2). 631–637. 18 indexed citations
17.
Wosikowski, Katja, Willy Küng, Max Hasmann, R. Löser, & Urs Eppenberger. (1993). Inhibition of growth‐factor‐activated proliferation by anti‐estrogens and effects on early gene expression of mcf‐7 cells. International Journal of Cancer. 53(2). 290–297. 40 indexed citations
18.
Dickstein, Bruce, Eva M. Valverius, Katja Wosikowski, et al.. (1993). Increased epidermal growth factor receptor in an estrogen‐responsive, adriamycin‐resistant MCF‐7 cell line. Journal of Cellular Physiology. 157(1). 110–118. 33 indexed citations
19.
Wosikowski, Katja, Urs Eppenberger, Willy Küng, Yoshikuni Nagamine, & Heinz Mueller. (1992). C-fos, C-jun and C-myc expressions are not growth rate limiting for the human MCF-7 breast cancer cells. Biochemical and Biophysical Research Communications. 188(3). 1067–1076. 14 indexed citations
20.
Eppenberger, Urs, Katja Wosikowski, & Willy Küng. (1991). Pharmacologic and Biologic Properties of Droloxifene, A New Antiestrogen. American Journal of Clinical Oncology. 14. 5–14. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Sugarman Breakdown of academic impact, for papers by Mélanie Di Benedetto Breakdown of academic impact, for papers by Denise K. Oelschlager Breakdown of academic impact, for papers by M V Blagosklonny Breakdown of academic impact, for papers by Robert D. Bruno Breakdown of academic impact, for papers by José M. Arencibia Breakdown of academic impact, for papers by Emily Powell Breakdown of academic impact, for papers by Willy Kueng Breakdown of academic impact, for papers by A. M. Burger Breakdown of academic impact, for papers by Shikha Gaur
Rankless by CCL
2026